The fate of thiopurine metabolites after switching to low-dose thiopurine with allopurinol or thioguanine in IBD patients: A retrospective analysis. [PDF]
Br J Clin PharmacolBayoumy AB +4 more
europepmc +1 more source
Multidrug resistance and myelomonocytic leukaemia in gaucher's disease [PDF]
, 2003 Baker, R +4 more
core
Investigation of 6-thioguanine as a strategy to overcome methotrexate resistance in a mouse model of leptomeningeal carcinomatosis. [PDF]
J NeurooncolNakagawa H +5 more
europepmc +1 more source
Population Pharmacokinetics Model of Thioguanine in Patients with Inflammatory Bowel Disease. [PDF]
Clin PharmacokinetBayoumy AB +3 more
europepmc +1 more source
Treatment-related mutagenic processes in acute lymphoblastic leukemia. [PDF]
HaematologicaVan der Ham CG +2 more
europepmc +1 more source
Integration of a standardized pharmacogenomic platform for clinical decision support at Boston Children's Hospital [PDF]
, 2012 Brownstein, Catherine A. +7 more
core +1 more source
Does allopurinol enhance efficacy of acute lymphoblastic leukemia maintenance therapy? [PDF]
HaematologicaSchmiegelow K, Toksvang LN, Conter V.
europepmc +1 more source
Severe myelosuppression and alopecia after thiopurine initiation in a patient with NUDT15 deficiency. [PDF]
Br J Clin PharmacolWu AS, Mozessohn L, Kim RB, Zipursky JS.
europepmc +1 more source
Automated Electrochemiluminescent immunoassay for N-terminal pro-BNP compared with IRMAs for ANP and BNP in heart failure patients and healthy individuals [PDF]
, 2003 A. Ripoli +5 more
core +1 more source
The NUDIX hydrolase NUDT5 influences purine nucleotide metabolism and thiopurine pharmacology. [PDF]
J Clin InvestKager L, Boztug K.
europepmc +1 more source